Delivery Order SPE2DB20D1050-SPE2DB25FH84P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 12, 2025. The award was made through open competition with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, is scheduled for completion by August 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,771.04 and an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a purchase of pharmaceutical products to support federal medical procurement needs, with performance to occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This delivery order was competitively awarded with firm fixed pricing and is scheduled for completion by September 16, 2025. The contract was awarded on August 25, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets (quantity: 30 units) under a firm fixed price contract. The award, valued at $16,626.24, has an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside delivery order represents a single procurement action against AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets (30-count units) with a contract ceiling value of $1,385.52. This non-set-aside competitive award is set for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52 and an ultimate completion date of September 9, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH84PDelivery Order
The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, was selected through open competition with no set-aside designation, demonstrating its capability to meet federal procurement requirements. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The parent IDC vehicle enables the company to deliver diverse pharmaceutical products across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Orgovyx, a prostate cancer treatment medication, reflects the company's role in furnishing specialized pharmaceutical commodities essential to the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/19/25 |